Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model-Reference-Cited by-同舟云学术

Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model

Published:2014-08-21 Issue:5 Volume:167 Page:651-663
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Nur Haneen¹²,Rao Luigia³,Frassanito Maria Antonia³,De Raeve Hendrik⁴,Ribatti Domenico⁵⁶,Mfopou Josué Kunjom⁷,Van Valckenborgh Els¹,De Bruyne Elke¹,Vacca Angelo³,Vanderkerken Karin¹,Menu Eline¹

Affiliation:

1. Department of Haematology and Immunology; Myeloma Centre Brussels; Vrije Universiteit Brussel (VUB); Brussels Belgium

2. Department of Biology; Faculty of Science and Technology; Hebron University; Hebron Palestine

3. Department of Biomedical Sciences and Human Oncology; University of Bari “AldoMoro” Medical School; Bari Italy

4. Department of Surgical Pathology; Universitair Ziekenhuis Brussel; Brussels Belgium

5. Department of Basic Medical Sciences; Neurosciences and Sensory Organs; University of Bari Medical School; Bari Italy

6. National Cancer Institute “Giovanni Paolo II”; Bari Italy

7. Cell Differentiation Unit; Diabetes Research Centre; Vrije Universiteit Brussel (VUB); Brussels Belgium

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13092/fullpdf

Reference79 articles.

1. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo;Angiolillo;The Journal of Experimental Medicine,1995

2. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1;Aoudjit;Journal of Immunology,1998

3. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases;Arenberg;The Journal of Experimental Medicine,1996

4. Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial;Bhutani;Leukemia,2014

5. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions;Brennan;Nature Reviews Immunology,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets;Frontiers in Oncology;2022-06-08

2. JAK/STAT Activation: A General Mechanism for Bone Development, Homeostasis, and Regeneration;International Journal of Molecular Sciences;2020-11-26

3. α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials;Frontiers in Immunology;2019-06-06

4. Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice;Cytokine;2018-11

5. Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin's lymphoma;ONCOL LETT;2017